Microbiology of Ventilator–Associated Pneumonia Compared With That of Hospital-Acquired Pneumonia

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Infection Control & Hospital Epidemiology

• Publication date

  2007-05-17

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1086/518460PMID 17564985
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ventilator-associated pneumonia

  2009cited by this paper
• Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia.

  2008cited by this paper
• Empfehlungen zur Prävention nosokomialer Pneumonien

  2005cited by this paper
• Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia.

  2005cited by this paper
• Both early-onset and late-onset ventilator-associated pneumonia are caused mainly by potentially multiresistant bacteria

  2005cited by this paper
• Multicenter study of hospital-acquired pneumonia in non-ICU patients.

  2005cited by this paper
• Guidelines for preventing health-care--associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee.

  2004cited by this paper
• A time-dependent analysis of intensive care unit pneumonia in trauma patients.

  2004cited by this paper
• Microbial Threats to Health

  2003cited by this paper
• Pneumonia in the intensive care unit

  2003cited by this paper
• Nosocomial pneumonia: emerging concepts in diagnosis, management, and prophylaxis

  2002cited by this paper
• Ventilator-associated pneumonia.

  2002cited by this paper
• Ventilator-associated pneumonia: European Task Force on ventilator-associated pneumonia Chairmen of the Task Force: A. Torres and J. Carlet

  2001cited by this paper
• Ventilator-associated pneumonia. European Task Force on ventilator-associated pneumonia.

  2001cited by this paper
• Increasing prevalence of antimicrobial resistance in intensive care units

  2001cited by this paper
• A comparative analysis of patients with early-onset vs late-onset nosocomial pneumonia in the ICU setting.

  2000cited by this paper
• Variations in etiology of ventilator-associated pneumonia across four treatment sites: implications for antimicrobial prescribing practices.

  1999cited by this paper
• Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System.

  1999cited by this paper
• Ventilator-associated pneumonia caused by potentially drug-resistant bacteria.

  1998cited by this paper
• Epidemiology of ventilator-acquired pneumonia based on protected bronchoscopic sampling.

  1998cited by this paper
• The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia.

  1998cited by this paper
• Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia.

  1997cited by this paper
• The value of routine microbial investigation in ventilator-associated pneumonia.

  1997cited by this paper
• Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit

  1996cited by this paper
• The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee.

  1995cited by this paper
• Nosocomial Pneumonia in Mechanically Ventilated Patients Receiving Antacid, Ranitidine, or Sucralfate as Prophylaxis for Stress Ulcer

  1994cited by this paper
• Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia.

  1993cited by this paper
• CDC definitions for nosocomial infections, 1988.

  1988cited by this paper

• Frequency of Resistant Microorganism Colonization and Risk Factors in Patients with Tracheostomy in Palliative Care

  2025cites this paper
• Modeling and simulation of distribution and drug resistance of major pathogens in patients with respiratory system infections

  2025cites this paper
• Outer membrane permeability of Pseudomonas aeruginosa through β-lactams: new evidence on the role of OprD and OpdP porins in antibiotic resistance

  2025cites this paper
• Nosocomial and Ventilator-associated Pneumonia

  2025cites this paper
• Pathogenic mechanisms and resistance profiles of microbial pulmonary infections in lung cancer: a systematic review

  2025cites this paper
• The clinical challenge of diagnosing Non-Ventilator Hospital Acquired Pneumonia and identifying causative pathogens - a narrative review.

  2024cites this paper
• Multidrug Resistant Pseudomonas aeruginosa in Clinical Settings: A Review of Resistance Mechanisms and Treatment Strategies

  2024cites this paper
• A Comparison of Different Strategies for Optimizing the Selection of Empiric Antibiotic Therapy for Pneumonia Caused by Gram-Negative Bacteria in Intensive Care Units: Unit-Specific Combination Antibiograms Versus Patient-Specific Risk Factors

  2024cites this paper
• Development of erythromycin loaded PLGA nanoparticles for improved drug efficacy and sustained release against bacterial infections and biofilm formation.

  2024cites this paper
• Epidemiological characteristics of ventilator-associated pneumonia in neurosurgery: A 10-year surveillance study in a Chinese tertiary hospital

  2024cites this paper
• Pseudomonas aeruginosa Bacteriophages and Their Clinical Applications

  2024cites this paper
• A Novel Bacteriophage Infecting Multi-Drug- and Extended-Drug-Resistant Pseudomonas aeruginosa Strains

  2024cites this paper
• Deciphering the microbial landscape of lower respiratory tract infections: insights from metagenomics and machine learning

  2024cites this paper
• Pathogenesis, Diagnosis and Therapeutic Strategies for Ventilator-associated Pneumonia

  2024cites this paper
• Age-dependent inflammatory response is altered in an ex vivo model of bacterial pneumonia

  2024cites this paper
• A computational approach to developing a multi-epitope vaccine for combating Pseudomonas aeruginosa–induced pneumonia and sepsis

  2024cites this paper
• Bacterial respiratory infections in patients with COVID-19: A retrospective study from a tertiary care center in Lebanon.

  2023cites this paper
• Comparison of Morbidity, Mortality, and Costs of VAP Patients with Non-VAP Patients in the Tertiary Referral Hospital of Kerman, Iran

  2023cites this paper
• Pseudomonas aeruginosa: Infections and novel approaches to treatment “Knowing the enemy” the threat of Pseudomonas aeruginosa and exploring novel approaches to treatment

  2023influential citation
• Microbiologic pattern and clinical outcome of non-ICU-acquired pneumonia: Korean HAP registry analysis

  2023cites this paper
• Adverse events during the COVID-19 pandemic in Ecuador: high frequency of healthcare-associated infections and increasing hospital stay and costs.

  2023cites this paper
• Empiric Treatment in HAP/VAP: “Don’t You Want to Take a Leap of Faith?”

  2022cites this paper
• Microbiologic pattern and clinical outcome of non-ICU-acquired pneumonia: Korean HAP registry analysis

  2022cites this paper
• 64: BACTERIAL RESPIRATORY INFECTIONS IN PATIENTS WITH COVID-19: A RETROSPECTIVE STUDY FROM A TERTIARY CARE CENTER IN LEBANON

  2022cites this paper
• Microbiology and Clinical Outcome of Hospital-Acquired Respiratory Infections in an Italian Teaching Hospital: A Retrospective Study

  2022cites this paper
• Epidemiology and Resistance Pattern In Microbial Pneumonia: A Review

  2022cites this paper
• Current Positioning against Severe Infections Due to Klebsiella pneumoniae in Hospitalized Adults

  2022cites this paper
• Treatment Heterogeneity in Pseudomonas aeruginosa Pneumonia

  2022cites this paper
• Insilico structure based drug design approach to find potential hits in ventilator-associated pneumonia caused by Pseudomonas aeruginosa

  2022cites this paper
• Review on Stenotrophomonas maltophilia: an emerging multidrug-resistant opportunistic pathogen.

  2022cites this paper
• Antibacterial Activity of the Novel Drug Gepotidacin against Stenotrophomonas maltophilia—An In Vitro and In Vivo Study

  2022cites this paper
• Pseudomonas aeruginosa as a Cause of Nosocomial Infections

  2021cites this paper
• Duration of antibiotic therapy for Enterobacterales and Pseudomonas aeruginosa: a review of recent evidence

  2021cites this paper
• Influence of microbiological culture results on antibiotic choices for veterans with hospital-acquired pneumonia and ventilator-associated pneumonia

  2021cites this paper
• Pneumonia

  2021cites this paper
• Antibacterial and antifungal activity of intraoral products containing phthalocyanine: in vitro study

  2021cites this paper
• Klebsiella Pneumoniae sepsis, clinical features and early outcome among Newborns in neonatal intensive care unit Zawia teaching hospital

  2020influential citation
• Cost-effectiveness Comparison of Ceftazidime/Avibactam Versus Meropenem in the Empirical Treatment of Hospital-acquired Pneumonia, Including Ventilator-associated Pneumonia, in Italy.

  2020cites this paper
• Exoenzyme Y induces extracellular active caspase-7 accumulation independent from apoptosis: Modulation of transmissible cytotoxicity.

  2020cites this paper
• Is ventilated hospital-acquired pneumonia a worse entity than ventilator-associated pneumonia?

  2020cites this paper
• 25th International Symposium on Infections in the Critically Ill Patient

  2020cites this paper
• Activity of tobramycin and polymyxin-E against Pseudomonas Activity of tobramycin and polymyxin-E against Pseudomonas aeruginosa biofilm coated medical grade endotracheal tubes. aeruginosa biofilm coated medical grade endotracheal tubes.

  2020influential citation
• Immunological considerations in the development of Pseudomonas aeruginosa vaccines

  2020cites this paper
• Optimizing the Use of Antibiotic Agents in the Pediatric Intensive Care Unit: A Narrative Review

  2020cites this paper
• Identification of Streptococcus pneumoniae in Hospital-acquired Pneumonia in Adults: A Systematic Review.

  2020cites this paper
• Perfil clínico, epidemiológico y microbiológico de los pacientes con neumonía en un hospital de Bogotá en el periodo de 2016-2019

  2020cites this paper
• Pharmacoinformatics approaches to identify potential hits against tetraacyldisaccharide 4′-kinase (LpxK) of Pseudomonas aeruginosa

  2020cites this paper
• A Review on Bacterial Respiratory Infections and Optimization of Their Identification

  2020cites this paper
• Lung and gut microbiota are altered by hyperoxia and contribute to oxygen-induced lung injury in mice

  2020cites this paper
• Hospital-Acquired Pneumonia in a Multipurpose Intensive Care Unit: One-Year Prospective Study.

  2019cites this paper
• Acinetobacter baumannii Is a Risk Factor for Lower Respiratory Tract Infections in Children and Adolescents With a Tracheostomy.

  2019cites this paper
• Age-Related Dysfunction in the Innate Immune Response to Lung Infections

  2019cites this paper
• Drug Prevention and Control of Ventilator-Associated Pneumonia

  2019cites this paper
• Development and validation of a semi-automated surveillance system—lowering the fruit for non-ventilator-associated hospital-acquired pneumonia (nvHAP) prevention☆

  2019influential citation
• The Use of Probiotics to Prevent Ventilator-Associated Pneumonia in Adults

  2019cites this paper
• Infection and Drug Resistance Dovepress

  2019cites this paper
• Intradermal vaccination with a Pseudomonas aeruginosa vaccine adjuvanted with a mutant bacterial ADP-ribosylating enterotoxin protects against acute pneumonia.

  2019cites this paper
• Risk Factors of Morbidity and Mortality in Patients with Pulmonary Acinetobacter Baumannii Infection of Emergency Intensive Care Unit

  2019cites this paper
• Stenotrophomonas maltophilia: More than Just a Colonizer!

  2019cites this paper
• Analysis of Phylogenetic Variation of Stenotrophomonas maltophilia Reveals Human-Specific Branches

  2018cites this paper
• Management of ventilator-associated pneumonia: Need for a personalized approach

  2018cites this paper
• Nosocomial Pneumonia in Patients Admitted to the Intensive Care Unit of a Tertiary Care Center in Mashhad, Northeast of Iran; an Etiologic Survey

  2018cites this paper
• Caracterización de neumonía por Staphylococcus aureus meticilino resistente en hospital militar de alta complejidad

  2018cites this paper
• Antibiotic treatment of hospital-acquired pneumonia: is it different from ventilator-associated pneumonia?

  2018cites this paper
• Nozokomiální pneumonie

  2018cites this paper
• Risk factors for pneumonia due to beta-lactam-susceptible and beta-lactam-resistant Pseudomonas aeruginosa: a case–case–control study

  2018cites this paper
• How to manage Pseudomonas aeruginosa infections

  2018cites this paper
• Stenotrophomonas maltophilia: From trivial to grievous

  2017cites this paper
• Ventilator-associated pneumonia: when is a pathogen not a pathogen?

  2017cites this paper
• New guidelines for nosocomial pneumonia

  2017cites this paper
• Should We Immediately Start Antibiotics in Every Patient with a Clinical Suspicion of HAP/VAP?

  2017cites this paper
• Anti-staphylococcal activity resulting from epithelial lining fluid (ELF) concentrations of amikacin inhale administered via the pulmonary drug delivery system

  2017cites this paper
• Pseudomonas aeruginosa infection liberates transmissible, cytotoxic prion amyloids

  2017cites this paper
• Combination antibiotic therapy and synergy in HAP and VAP

  2017cites this paper
• Probable Treatment Options against Infections with Bacteria Carrying blaNDM-1 Gene

  2017cites this paper
• Impact of VAP bundle adherence among ventilated critically ill patients and its effectiveness in adult ICU

  2017cites this paper
• Pneumonia in Trauma Patients

  2017cites this paper
• “ ISOLATION AND IDENTIFICATION OF AEROBIC BACTERIA FROM VENTILATOR ASSOCIATED PNEUMONIA AND ITS ANTIBIOGRAM FROM TERTIARY CARE CENTER , KANPUR ”

  2017cites this paper
• COMPARATIVE CLINICAL TRIAL BETWEEN BRONCHOSCOPIC A ND NON-BRONCHOSCOPIC BRONCHOALVEOLAR LAVAGE IN DIAGNOSIS O F VENTILATOR ASSOCIATED PNEUMONIA ”

  2017cites this paper
• BACTERIAL PATHOGENS OF NOSOCOMIAL INFECTIONS IN ICUS AND THEIR ANTIBIOTICS RESISTANT PATTERN AT KING KHALID HOSPITAL IN AL-KHARJ/SAUDI ARABIA

  2017cites this paper
• Predictive value of different scoring systems for critically ill patients with hospital acquired pneumonia

  2016cites this paper
• Non-Intensive Care Unit Acquired Pneumonia: A New Clinical Entity?

  2016influential citation
• Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society.

  2016cites this paper
• Management of Adults with Hospital-acquired and Ventilator-associated Pneumonia.

  2016cites this paper
• Innate immune responses in the ageing lung

  2016cites this paper
• The Effect of a Nationwide Infection Control Program Expansion on Hospital-Onset Gram-Negative Rod Bacteremia in 130 Veterans Health Administration Medical Centers: An Interrupted Time-Series Analysis.

  2016cites this paper
• Biomedical applications of nisin

  2016cites this paper
• Clinical MRSA isolates from skin and soft tissue infections show increased in vitro production of phenol soluble modulins.

  2015cites this paper
• Polymicrobial interactions in infections: the case Pseudomonas aeruginosa and Candida albicans in ventilator-associated pneumonia

  2015cites this paper
• Staphylococcus aureus (Including Staphylococcal toxic shock)

  2015cites this paper
• Higienização bucal com digluconato de clorexidina e extrato etanólico de própolis em pacientes de Unidade de Terapia Intensiva (UTI) de um Hospital Público na cidade de

  2015cites this paper
• The current pathogens and treatment of hospital-acquired pneumonia/ventilator-associated pneumonia in medical intensive care units

  2015cites this paper
• Nosocomial Isolates and Their Drug Resistant Pattern in ICU Patients at National Institute of Neurological and Allied Sciences, Nepal

  2015cites this paper
• Pseudomonas aeruginosa Nosocomial Pneumonia: Impact of Pneumonia Classification

  2015cites this paper
• Pseudomonas aeruginosa toxins

  2015cites this paper
• In vitro interaction of Stenotrophomonas maltophilia with human monocyte-derived dendritic cells

  2015influential citation
• Biofilm-based Healthcare-associated Infections

  2015cites this paper
• Epidemiology, etiology, and risk factors of bacterial pneumonia

  2015cites this paper
• Links between Anr and Quorum Sensing in Pseudomonas aeruginosa Biofilms

  2015cites this paper
• Stenotrophomonas maltophilia Infections in Adults: Primary Bacteremia and Pneumonia

  2015cites this paper